Division of Pulmonary, Allergy and Critical Care

Thoracic oncology conducts cutting-edge diagnostic and therapeutic research related to lung cancer and malignant mesothelioma.

Faculty members in Penn Medicine's pulmonary division, led by Steven Albelda, MD, interact closely with faculty from thoracic surgery, oncology and pathology to conduct cutting-edge diagnostic and therapeutic investigations related to lung cancer and malignant mesothelioma.

Research from this group is supported by an NCI-funded program project, and a grant from the Pennsylvania Department of Health and Foundation.

Members of the group and their research interests include:

Pulmonary

Steven Abelda, MD

  • Preclinical studies of immunogene therapy for lung cancer and mesothelioma
  • Immune analysis of clinical trials using gene therapy or immunotherapy
  • Mesothelioma and cancer genomics
  • Personalized medicine

Melpo Christofidou-Solomidou, PhD

  • Chemoprevention of lung carcinogenesis and evaluation of anti-carcinogenic effects of common botanicals

Andrew Haas, MD, PhD

  • Clinical trials using gene therapy or immunotherapy to treat malignant mesothelioma and lung cancer
  • Interventional bronchoscopy treatment of COPD

Anil Vachani, MD

  • Determination of markers to predict survival after lung cancer surgery
  • Discovery of biomarkers for early detection of lung cancer
  • Gene environment interactions in lung cancer

Thoracic Surgery

Sunil Singhal, MD

  • Combining surgery with immunotherapy

Oncology

Corey Langer, MD







Share This Page: